Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Docetaxel and Cetuximab in Treating Patients With Metastatic Prostate Cancer

This study has been completed.
Information provided by (Responsible Party):
Swiss Group for Clinical Cancer Research Identifier:
First received: August 5, 2008
Last updated: April 9, 2013
Last verified: April 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2010
  Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)